CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Prasad Raju Chief Financial Officer | Sale | −3,524 | $72.69 | $256K | 6,476 |
| 2024-03-15 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −10,613 | $71.97 | $764K | 217,509 |
| 2024-03-15 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −9,387 | $73.06 | $686K | 208,122 |
| 2024-03-12 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,146 | $74.44 | $85K | 61,174 |
| 2024-03-12 | Kulkarni Samarth Chief Executive Officer | Sale | −4,583 | $74.44 | $341K | 208,122 |
| 2024-03-11 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,801 | $78.26 | $219K | 60,070 |
| 2024-03-11 | Kulkarni Samarth Chief Executive Officer | Sale | −9,802 | $78.26 | $767K | 203,705 |
| 2024-02-20 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,913 | $79.67 | $152K | 57,371 |
| 2024-02-20 | Kulkarni Samarth Chief Executive Officer | Sale | −6,370 | $79.67 | $507K | 194,257 |
| 2024-02-15 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −12,949 | $79.94 | $1.0M | 194,428 |
| 2024-02-15 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −5,951 | $81.04 | $482K | 188,477 |
| 2024-02-15 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −1,100 | $81.66 | $90K | 187,377 |
| 2024-01-29 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −49,300 | $60.50 | $3.0M | 188,077 |
| 2024-01-29 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −700 | $61.10 | $43K | 187,377 |
| 2024-01-16 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −20,000 | $62.50 | $1.3M | 187,377 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −7,301 | $63.61 | $464K | 405,076 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −5,999 | $64.46 | $387K | 399,077 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −9,300 | $65.63 | $610K | 389,777 |
| 2023-05-30 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −2,400 | $66.83 | $160K | 387,377 |
| 2023-04-25 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −20,607 | $50.50 | $1.0M | 391,770 |
Page 4 of 27 · 528 trades